New Report Available: Cough, Cold and Allergy (Hay Fever) Remedies in Switzerland

Cough, cold and allergy (hay fever) remedies is an extremely seasonal category, and its performance is strongly related to environmental conditions such as the weather and seasonal change, pollen levels and the spread of flu, as well as urban pollution and its effects on consumers. The flu epidemic at the beginning of 2013 was reported to be the worst since 2008/09. Thus, the performance of cough, cold and allergy (hay fever) remedies saw an improvement in 2013.

Competitive Landscape

Novartis Consumer Health AG led sales of cough, cold and allergy (hay fever) remedies in 2013. The company maintained its leading position in this category throughout the review period, due to the strong value sales of brands such as Neo Citran, Otrivin and Mebucaine. The company also holds the leading position in paediatric cough, cold and allergy remedies, with brands such as Vibrocil and Pulmex. Novartis is a well-known and well-trusted pharmaceutical company in Switzerland and profits from its good reputation with Swiss consumers. In 2013, Novartis launched cough suppressants under the Neo Citran brand (alongside the existing syrup, tablets and drops).

Full Report Details at
- http://www.fastmr.com/prod/887753_cough_cold_and_allergy_hay_fever_remedies_in.aspx?afid=301

Industry Prospects

Cough, cold and allergy (hay fever) remedies is expected to see an increase in value sales over the forecast period, rising at an anticipated CAGR of 1% at constant 2013 prices. There are several reasons for the moderate growth of this category. For example, the category of cough, cold and allergy (hay fever) remedies is mature and demand for these products is expected to remain stable throughout the forecast period. In addition, the number of Swiss consumers suffering from hay fever is increasing each year, which will lead to a rise in the sales of antihistamines/allergy remedies. Moreover, dynamic products such as medicated confectionery will continue to drive sales. However, the growth of the category is also dependent on external factors that are difficult to predict, such as weather conditions, pollen levels and the length/harshness of the winter season. The expected forecast period performance is thus expected to be broadly in line with (slightly slower than) that of the review period.

Report Overview

Discover the latest market trends and uncover sources of future market growth for the Cough, Cold and Allergy (Hay Fever) Remedies industry in Switzerland with research from Euromonitor's team of in-country analysts.

Find hidden opportunities in the most current research data available, understand competitive threats with our detailed market analysis, and plan your corporate strategy with our expert qualitative analysis and growth projections.

If you're in the Cough, Cold and Allergy (Hay Fever) Remedies industry in Switzerland, our research will save you time and money while empowering you to make informed, profitable decisions.



About Fast Market Research

Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget.

For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.

You may also be interested in these related reports:

- Cough, Cold and Allergy (Hay Fever) Remedies in Romania
- Cough, Cold and Allergy (Hay Fever) Remedies in Japan
- Cough, Cold and Allergy (Hay Fever) Remedies in Germany
- Cough, Cold and Allergy (Hay Fever) Remedies in Taiwan
- Cough, Cold and Allergy (Hay Fever) Remedies in South Korea